Veterinary Medicines

Lincomycin 20% 226,8 mg/ml Injektionslösung für Schwein, Hund und Katze

Authorised
  • Lincomycin hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
Lincomycin 20% 226,8 mg/ml Injektionslösung für Schwein, Hund und Katze
Active substance:
  • Lincomycin hydrochloride monohydrate
Target species:
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Lincomycin hydrochloride monohydrate
    226.80
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
    • Pig
      • Meat and offal
        7
        day
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6324412.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 20/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."